The Recall Desk
HighFDA (Devices)·Z-0575-2015·Announced 2014-12-17

INOmax DSIR Nitric Oxide System Recalled for Monitoring Error

INO Therapeutics is recalling nine INOmax DSIR Nitric Oxide delivery systems because they may report lower-than-expected NO concentrations.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall involves a medical device used in neonatal care where a monitoring error could lead to incorrect therapy administration, representing a risk of harm without reported injuries.

Plain-English summary

INO Therapeutics (dba Ikaria) is recalling nine INOmax DSIR Nitric Oxide delivery systems, Model 10007, software version 3.1.0. The recall affects devices manufactured using a specific version of the Monitoring Circuit Board.

The recall is due to an issue that could result in monitored Nitric Oxide (NO) concentration reporting lower than expected. The affected devices are used primarily in Neonatal Intensive Care Units (NICU) and for the transport of neonates.

The affected units were distributed in Virginia and Pennsylvania. The specific serial numbers for the recalled devices are DS20080152, DS20090925, DS20101076, DS20101499, DS20110886, DS20110965, DS20120099, DS20120150, and DS20120169.

The recalled product

Product
INOMAX DSIR Nitric Oxide delivery system, Model 10007, software version 3.1.0., delivers INOMAX (nitric oxide for inhalation) therapy gas and provides continuous monitoring of inspired O2, NO2, and NO, and comprehensive alarm systems. The primary clinical settings are Neonatal In
Affected units
9

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (9)

  • Serial Numbers: DS20080152
  • DS20090925
  • DS20101076
  • DS20101499
  • DS20110886
  • DS20110965
  • DS20120099
  • DS20120150
  • DS20120169.

Distribution

Distributed in 2 states: